Mouse Anti-TBEV Recombinant Antibody (clone 10C2) (CAT#: FAMAB-0133JF)

Figure 1 Western blot of a lysate of TBEV-infected cells was prepared.

Reactivity of mouse sera with TBEV proteins.

Kreil, T. R., Maier, E., Fraiss, S., & Eibl, M. M. (1998). Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. Journal of virology, 72(4), 3076-3081.

Figure 2 Active immunity to TBEV. Female BALB/c mice were administered s.c. 0.2 ml of a 1:10-diluted human TBEV Ig preparation 2 h before they were injected i.p. with different amounts of TBEV.

Differences in the survival of groups of mice were compared to the survival of mice which received UV-inactivated TBEV instead of the initial TBEV challenge by a two-sided log-rank test, and significances are indicated by asterisks.

Kreil, T. R., Maier, E., Fraiss, S., & Eibl, M. M. (1998). Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. Journal of virology, 72(4), 3076-3081.

Figure 3 Brain, thalamus, severe lymphohistiocytic perivascular infiltration of neuroparenchyma and gliosis.

Original magnification ×200.

Böhm, B., Schade, B., Bauer, B., Hoffmann, B., Hoffmann, D., Ziegler, U., ... & Böttcher, J. (2017). Tick-borne encephalitis in a naturally infected sheep. BMC veterinary research, 13(1), 267.